37085-55-5

Upstream product

• 137121-87-0 α/β-D-thymidine 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1207863-28-2 1-(2,3-dideoxy-3-fluoro-5-O-tosyl-β-D-erythro-pentofuranosyl)thymine 
• 169203-45-6 1-(2,3-dideoxy-3-fluoro-β-D-erythro-pentofuranosyl)-2-thiothymine 
• 179043-89-1 Methanesulfonic acid (2R,3R,5R)-2-[(benzyl-methanesulfonyl-amino)-methyl]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 
• 179238-65-4 1-(2,5-dideoxy-β-L-glycero-pent-4-enofuranosyl)thymine 
• 179043-85-7 1-[(2R,4R,5R)-5-(Benzylamino-methyl)-4-hydroxy-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 

Relevant academic research and scientific papers

Novel P1,P2-substituted phosphonate analogues of 2'-deoxyadenosine and 2'-deoxythymidine 5'-triphosphates

P1,P2-Substituted methylene, fluoromethylene, and difluoromethylene analogues of the deoxynucleotides 2'-deoxyadenosine 5'-triphosphate and thymidine 5'-triphosphate have been prepared by reaction between the bisphosphonic acid and t

Process for preparing 2-thiouracil nucleosides

Some new 1-(2- or 3-deoxy-β-D-pentofuranosyl)-2-thiouracils and 1-β-D-pentofuranosyl-2-thio-6-azauracils have been prepared. Further, it has been found that the known nucleoside compound, 1-β-D-ribofuranosyl-2-thiouracil is active against Herpes virus and against L-1210 leukemia in mice. An improved method of preparing corresponding 2-0-methyluracil and 2-0-methyl-6-azauracil intermediates is described. The method preserves the β-configuration of the starting nucleoside.